BALAMINES - Balaji Amines Ltd. Share Price

Chemicals & Petrochemicals

₹1286.40-14.20(-1.09%)

Market Closed as of Apr 28, 2025, 15:30 IST

What does Balaji Amines Ltd. do?

Specialty Chemicals•Chemicals•Small Cap

Balaji Amines Limited engages in the manufacture and sale of methylamines, ethylamines, and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments, Chemicals and Hotel. It offers monomethylamine, dimethylamine, trimethylamine, monoethylamine, diethylamine, triethylamine, and dimethyl and diethyl amino ethanol; and specialty chemicals, including N-methyl pyrrolidone, morpholine, 2-pyrrolidone, N-ethyl-2-pyrrolidone, gamma-butyrolactone, dimethylformamide, acetonitrile, dimethylcarbonate, propylene glycol, and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide, di-methyl amine hydrochloride, tri-methyl amine hydrochloride, di-ethyl amine hydrochloride, tri-ethyl amine hydrochloride, di-methyl urea, choline chloride, mono-ethyl amine hydrochloride, and benzyl tri ethyl ammonium chloride; and pharma excipients, such as poly vinyl pyrrolidone. In addition, it operates Balaji Sarovar Premiere, a hotel in Solapur, Maharashtra, as well as engages in the provision of hotel, restaurant, and hospitality services. The company serves pharmaceutical, agrochemical, paint and resin, animal feed, oil and gas, rubber cleaning chemical, dye and textile, pesticides and insecticides, water treatment chemical, optical brighteners, corrosion inhabitations, cosmetics, explosives, and foundry chemicals industries. It also exports its products to the United States, the United Kingdom, Argentina, Latin America, Canada, Israel, Australia, Bangladesh, Germany, Italy, Egypt, South Africa, and internationally. Balaji Amines Limited was incorporated in 1988 and is headquartered in Solapur, India.

Industry Group:Chemicals & Petrochemicals

Employees:1,084

Website:www.balajiamines.com

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Rank

Balance Sheet

Momentum

Technicals

Smart Money

Insider Trading

Sector Comparison: BALAMINES vs Chemicals & Petrochemicals

Comprehensive comparison against sector averages

Comparative Metrics

BALAMINES metrics compared to Chemicals

Category	BALAMINES	Chemicals
PE	22.11	54.41
PS	2.82	4.58
Growth	-13.5 %	7.3 %

Performance Comparison

BALAMINES vs Chemicals (2021 - 2025)

Key Insights

1. BALAMINES is NOT among the Top 10 largest companies in Specialty Chemicals.
2. The company holds a market share of 1.1% in Specialty Chemicals.
3. In last one year, the company has had a below average growth that other Specialty Chemicals companies.

Share Holdings

Understand Balaji Amines ownership landscape with insights into key distribution patterns, offering investors a clear view of stakeholder dynamics.

Holding Pattern

Major Shareholders

Share Holding Details

As of 2025-03-31

Shareholder Name	Holding %
ANDE PRATHAP REDDY	15.34%
APR HOLDING AND INVESTMENTS LLP	14.74%
ANDE SRINIVAS REDDY	11.29%
HEMANTH REDDY GADDAM	2.52%
VIJAYA NALLA	2.13%
VINEEL REDDY NALLA	2.13%
KISHAN REDDY NALLA	2.07%
VINITHA NALLA	2.05%
MANOHAR DEVABHAKTUMI	1.85%
N RAJESHWAR REDDY	1.84%
GADDAM MADHUMATHI	1.77%
NOMULA SARITA	1.53%
VEERA REDDY YANNAM SRINIVAS REDDY YANNAM	1.5%
RAM REDDY DUNDURAPU	1.47%
VIJAYALAXMI YANNAM VEERA REDDY YANNAM SRINIVAS REDDY YANNAM	1.25%
ACHANTA ANNAPURNA	0.97%
DEEPTI RAJESHWAR REDDY NOMULA	0.94%
DUNDURAPU VANDANA	0.71%
A MEENA DEVI	0.44%
NOMULA EESHAN REDDY	0.36%

Overall Distribution

Distribution across major stakeholders

Ownership Distribution

Distribution across major institutional holders

Summary of Latest Earnings Report from Balaji Amines

Summary of Balaji Amines's latest earnings call, featuring management's outlook on business performance, financial results, and analyst Q&A sessions that highlight key strategic initiatives and market challenges.

Earnings Outlook

Last updated: Nov 24

Management Outlook & Major Points:
Balaji Amines' management remains optimistic about long-term growth despite near-term challenges. Key highlights:

Improved Margins & Strategic Focus:
- EBITDA margins rose 110 bps QoQ to 20% in Q2FY25, driven by higher-margin products.
- API and agrochemical sectors identified as long-term growth drivers.
Capacity Expansion:
- Commissioned a new Methyl Amine plant (Unit IV), doubling capacity to 88,000 MT annually. Full utilization expected by FY26-27.
- Upcoming projects: DMC/Propylene Glycol upgrade (commissioning in FY25), Di-Methyl Ether plant (FY25/Q1FY26), Isopropyl Amines (FY25), and N-Methyl Morpholine (FY25).
Cost Leadership & Quality:
- Methyl Amine plant provides cost advantage vs. competitors.
- Achieved BIS certification for Morpholine (only Indian manufacturer), enhancing market reputation.
Sustainability Initiatives:
- 20 MW solar plant (8 MW DC in FY25) to reduce power costs and carbon footprint.
New Product Launches:
- Expanding into NBPT (2,500 TPA), Acetonitrile (60 MT/day), and specialty chemicals (e.g., Hydrogen Cyanide, EDTA) via subsidiary Balaji Specialty Chemicals (mega-project status in Maharashtra).
Financial Resilience:
- Maintains debt-free status; expansions funded via internal accruals (exceptions: BSCL Phase-2 may require limited debt).
- H1FY25 standalone revenue: Rs.664 Cr, EBITDA margin at 19%, PAT Rs.81 Cr.
Market Opportunities:
- DME Blending: Awaiting BIS notification (expected Nov 2024) for LPG blending; potential game-changer.
- EV/Battery Chemicals: Ready with NMP and DMC but delays in customer production timelines.
Volume & Price Outlook:
- Targets 10-12% volume growth in FY25.
- Prices stabilizing post-China dumping pressure; recovery expected by FY25-end.

Challenges:

Slow adoption of DME and battery chemicals.
Chinese dumping in DMF, NMP, and EDA markets.

Growth Targets:

Revenue aims of Rs.3,000"“4,000 Cr in 2"“3 years with stabilized pricing and new capacities.

Q&A Session

Last updated: Nov 24

Question: When do you think we get the gazette notification for blending of DME with LPG?
Answer: The notification is pending publication and expected by the end of November 2024.

Question: What capacity utilization can be expected for the DME plant in its first year?
Answer: Full utilization will take time due to market acceptance challenges as DME is a new product in India, but it is anticipated to be a game-changer.

Question: Can we expect 100% capacity utilization for DMF post Methyl Amine plant commissioning, and what about anti-dumping measures?
Answer: Targeting 80-85% DMF capacity utilization; anti-dumping duties may be pursued if import pricing pressures persist.

Question: What are the timelines for BSCL Unit 2's Phase-1 and Phase-2 CAPEX?
Answer: Phase-1 will complete in 11"“12 months, with Phase-2 following 12 months after Phase-1's commissioning.

Question: What updates exist on de-bottlenecking BSC Unit 1 to boost Piperazine/DETA production?
Answer: Modifications are ongoing to enable higher-value products like TETA and AEP, with results expected in 4"“6 months.

Question: Provide FY25 volume guidance and pricing trends.
Answer: Targeting 10"“12% standalone volume growth for FY25, with price stabilization anticipated by year-end.

Question: Who are the target customers for MIPA/DIPA, and how will CAPEX be funded?
Answer: Pharma and agro industries; CAPEX for new plants will use internal accruals, with minimal borrowing for specialty chemicals.

Question: Have battery manufacturers placed orders for chemicals like NMP?
Answer: No orders yet due to delayed manufacturing starts; Balaji is prepared to supply once production commences.

Question: Quantify DME's revenue and margins at full capacity.
Answer: Margins are unclear due to market unpredictability but could stabilize at 18"“22% post-commissioning after 6"“12 months.

Question: What is the H2 outlook for specialty chemicals amid Chinese dumping?
Answer: Volumes may rise for DMF/NMP despite low margins; standalone revenue could reach Rs.1,300"“1,400 crore annually.

Question: What is the revenue projection post-CAPEX completion in 2"“2.5 years?
Answer: Anticipated revenue of Rs.3,000"“4,000 crore if product prices stabilize at reasonable levels.

Question: How will new Methyl Amine technology affect older plants?
Answer: Older plants remain relevant for other amines; new tech allows dedicated DMA production (110 tons/day) without by-products.

Question: Why pursue aggressive CAPEX amid delays in DME/blending and battery chemicals?
Answer: Investments align with government policies and future demand for import-substituted products, funded largely via internal accruals.

Question: What is the DME plant's EBITDA potential?
Answer: Projected EBITDA margins of 18"“22% once operational, contingent on market dynamics.

Question: Is Chinese pricing pressure easing?
Answer: Some stabilization observed, with price recovery expected by next quarter as global anti-dumping measures impact Chinese exports.

Income Statement for Balaji Amines

Standalone figures (in Rs. Crores) / View Consolidated Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	-22.5%	1,338	1,726	1,918	1,228	919	950
Other Income	128.3%	21	9.76	12	12	10	5.22
Total Income	-21.7%	1,359	1,736	1,930	1,240	929	955
Cost of Materials	-24.4%	768	1,015	1,126	612	482	548
Employee Expense	-10.1%	72	80	89	66	50	48
Finance costs	-31.8%	2.18	2.73	7.04	5.33	12	13
Depreciation and Amortization	10%	34	31	29	23	24	20
Other expenses	-15.5%	263	311	309	213	178	186
Total Expenses	-21.3%	1,127	1,431	1,507	930	776	789
Profit Before exceptional items and Tax	-24%	232	305	423	310	154	166
Exceptional items before tax	-	0	0	0	0	4.28	3.56
Total profit before tax	-24%	232	305	423	310	158	170
Current tax	-28.2%	52	72	111	81	40	52
Deferred tax	38.1%	8.29	6.28	3.96	-3.09	4.24	0
Total tax	-23.4%	60	78	115	78	44	52
Total profit (loss) for period	-25.1%	171	228	308	232	114	118
Other comp. income net of taxes	-403.4%	-4.84	-0.16	0	0	0	0
Total Comprehensive Income	-27%	166	227	308	232	114	118
Earnings Per Share, Basic	-25%	52.87	70.18	95.04	71.52	35.11	36.44
Earnings Per Share, Diluted	-25%	52.87	70.18	95.04	71.52	35.11	36.44

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-6.6%	299	320	333	367	308	325
Other Income	-16%	5.45	6.3	5.23	5.78	5.82	5
Total Income	-6.5%	305	326	338	373	314	330
Cost of Materials	-8.2%	169	184	176	208	163	175
Employee Expense	-5.9%	17	18	17	22	18	16
Finance costs	-34.1%	0.41	0.56	0.42	0.6	0.61	0.54
Depreciation and Amortization	9.4%	9.85	9.09	9.07	9.35	7.9	8.28
Other expenses	-3%	66	68	70	66	62	67
Total Expenses	-5.2%	258	272	283	288	259	286
Profit Before exceptional items and Tax	-13.2%	47	54	55	85	56	44
Total profit before tax	-13.2%	47	54	55	85	56	44
Current tax	-22.4%	7.98	10	12	17	13	10
Deferred tax	-17.8%	3.17	3.64	2.09	5.42	0.93	0.84
Total tax	-23.1%	11	14	14	22	14	11
Total profit (loss) for period	-10.3%	36	40	41	63	42	33
Other comp. income net of taxes	-	0	0	0	-3.9	0.05	-0.73
Total Comprehensive Income	-10.3%	36	40	41	59	42	32
Earnings Per Share, Basic	-12.7%	11.01	12.47	12.51	19.32	12.82	10.09
Earnings Per Share, Diluted	-12.7%	11.01	12.47	12.51	19.32	12.82	10.09

Consolidated figures (in Rs. Crores) / View Standalone Data

AnnualQuarterly

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022	Mar-2021	Mar-2020	Mar-2019
Revenue From Operations	-30.3%	1,642	2,355	2,320	1,311	936	943
Other Income	107.1%	30	15	7.25	6.07	5.01	4.23
Total Income	-29.5%	1,671	2,371	2,328	1,318	941	947
Cost of Materials	-27.4%	916	1,261	1,276	616	498	541
Employee Expense	-3.6%	82	85	92	68	51	48
Finance costs	-50.5%	6.44	12	17	18	23	13
Depreciation and Amortization	-2.2%	45	46	42	34	32	20
Other expenses	-20%	332	415	376	240	190	186
Total Expenses	-24.1%	1,370	1,804	1,749	991	810	782
Profit Before exceptional items and Tax	-46.8%	302	567	578	327	131	165
Exceptional items before tax	-	0	0	0	0	4.35	3.56
Total profit before tax	-46.8%	302	567	578	327	135	169
Current tax	-57.5%	63	147	140	81	40	52
Deferred tax	-59.5%	6.26	14	21	1.75	-2.02	0
Total tax	-57.5%	69	161	160	83	38	52
Total profit (loss) for period	-43%	232	406	418	244	97	117
Other comp. income net of taxes	-373.2%	-4.82	-0.23	0	0	0	0
Total Comprehensive Income	-44.1%	227	405	418	244	97	117
Earnings Per Share, Basic	-37.4%	63.22	100.47	113.71	73.52	32.34	36.14
Earnings Per Share, Diluted	-37.4%	63.22	100.47	113.71	73.52	32.34	36.14

Description	(%) Q/Q	Dec-2024	Sep-2024	Jun-2024	Mar-2024	Dec-2023	Sep-2023
Revenue From Operations	-9.8%	313	347	385	414	383	381
Other Income	-16.2%	7.86	9.19	8.13	8.76	8.46	6.77
Total Income	-9.9%	321	356	393	423	392	387
Cost of Materials	-24.4%	168	222	193	244	201	191
Employee Expense	0%	19	19	19	25	21	19
Finance costs	-433.3%	0.8	1.06	0.99	1.31	1.54	1.77
Depreciation and Amortization	0%	12	12	12	12	11	11
Other expenses	-10.3%	71	79	82	79	77	85
Total Expenses	-6.4%	280	299	331	330	322	339
Profit Before exceptional items and Tax	-28.6%	41	57	62	93	70	48
Total profit before tax	-28.6%	41	57	62	93	70	48
Current tax	-47.6%	6.24	11	14	15	14	11
Deferred tax	-18%	3.51	4.06	2.27	5.01	0.87	0.54
Total tax	-37.5%	9.75	15	16	20	14	12
Total profit (loss) for period	-25%	31	41	46	72	56	36
Other comp. income net of taxes	-	0	0	0	-4.06	-0.15	-0.52
Total Comprehensive Income	-25%	31	41	46	68	56	36
Earnings Per Share, Basic	-20.7%	10.24	12.65	13.36	21	15.24	10.71
Earnings Per Share, Diluted	-20.7%	10.24	12.65	13.36	21	15.24	10.71

Balance Sheet for Balaji Amines

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	-6.7%	29	31	25	91	47	30
Current investments	-	0	0	0	62	25	0
Loans, current	-	1.18	0	0	0	0	0
Total current financial assets	0.6%	471	468	482	484	393	484
Inventories	-6.1%	247	263	202	267	363	203
Current tax assets	-	-	0	1.78	1.54	144	108
Total current assets	-6%	718	764	701	774	920	816
Property, plant and equipment	-0.6%	715	719	593	599	605	495
Capital work-in-progress	52.1%	214	141	153	74	35	141
Investment property	-2.5%	4.91	5.01	5.12	5.22	0	0
Non-current investments	0%	66	66	66	66	66	66
Loans, non-current	-	0	0	0	0	0	66
Total non-current financial assets	-19.4%	80	99	71	70	70	242
Total non-current assets	5.3%	1,023	972	865	777	734	883
Total assets	0.3%	1,741	1,736	1,566	1,551	1,654	1,699
Total non-current financial liabilities	16.7%	1.07	1.06	2.55	1	0	122
Provisions, non-current	-76.4%	1.77	4.26	1.59	1.81	0	0
Total non-current liabilities	4.2%	76	73	66	63	58	175
Borrowings, current	-	0	0	0	0	0	0
Total current financial liabilities	-35.9%	76	118	55	82	100	165
Provisions, current	-81.8%	1.34	2.87	0.18	0.25	1.51	52
Current tax liabilities	-28.2%	2.27	2.77	4.96	0	156	111
Total current liabilities	-33.9%	85	128	66	88	269	331
Total liabilities	-20.4%	161	202	132	151	327	506
Equity share capital	0%	6.48	6.48	6.48	6.48	6.48	6.48
Total equity	3%	1,580	1,534	1,434	1,400	1,326	1,192
Total equity and liabilities	0.3%	1,741	1,736	1,566	1,551	1,654	1,699

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Sep-2024	Mar-2024	Sep-2023	Mar-2023	Sep-2022	Mar-2022
Cash and cash equivalents	90%	153	81	143	148	56	33
Current investments	-	0	0	0	73	25	0
Total current financial assets	-7.7%	609	660	697	687	573	640
Inventories	2.8%	295	287	234	303	454	222
Current tax assets	-	0	0	1.78	0	144	133
Total current assets	-5.6%	941	997	969	1,033	1,207	1,042
Property, plant and equipment	-1%	882	891	766	775	784	681
Capital work-in-progress	39.6%	283	203	196	113	35	141
Investment property	-2.5%	4.91	5.01	5.12	5.22	0	0
Total non-current financial assets	14.8%	7.99	7.09	6.92	6.15	6.08	5.99
Total non-current assets	5.5%	1,212	1,149	1,020	930	849	833
Total assets	0.3%	2,153	2,146	1,989	1,963	2,056	1,875
Borrowings, non-current	-49.4%	6.06	11	17	30	44	58
Total non-current financial liabilities	-44.3%	7.13	12	19	31	44	73
Provisions, non-current	-74.1%	1.89	4.44	1.68	1.82	0.13	0
Total non-current liabilities	-1%	103	104	104	115	125	142
Borrowings, current	0%	9.09	9.09	27	27	67	16
Total current financial liabilities	-31.6%	94	137	95	138	190	222
Provisions, current	-80.1%	1.38	2.91	0.21	0.32	1.53	55
Current tax liabilities	13.5%	4.02	3.66	14	5.65	175	138
Total current liabilities	-29.7%	105	149	116	149	371	418
Total liabilities	-17.5%	209	253	220	265	496	560
Equity share capital	0%	6.48	6.48	6.48	6.48	6.48	6.48
Non controlling interest	1.8%	174	171	161	144	115	65
Total equity	2.7%	1,945	1,893	1,769	1,698	1,559	1,315
Total equity and liabilities	0.3%	2,153	2,146	1,989	1,963	2,056	1,875

Investor Care
Dividend Yield	0.64%
Dividend/Share (TTM)	11
Shares Dilution (1Y)	0.00%
Diluted EPS (TTM)	57.25

Financial Health
Current Ratio	8.93
Debt/Equity	0.01
Debt/Cashflow	11.15

Cash Flow for Balaji Amines

Standalone figures (in Rs. Crores) / View Consolidated Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	-31.8%	2.18	2.73	7.04
Change in inventories	105.5%	4.59	-64.6	-106.71
Depreciation	10%	34	31	29
Adjustments for interest income	320.7%	14	4.09	0
Net Cashflows from Operations	-23.8%	219	287	249
Income taxes paid (refund)	-36.6%	46	72	81
Net Cashflows From Operating Activities	-20.5%	172	216	168
Proceeds from sales of PPE	-14.1%	0.03	0.15	0.27
Purchase of property, plant and equipment	193.3%	221	76	148
Purchase of intangible assets	-	1.92	0	0
Interest received	339.2%	14	3.96	0
Other inflows (outflows) of cash	-	63	0	30
Net Cashflows From Investing Activities	-10.4%	-146.18	-132.37	-117.85
Dividends paid	72.2%	32	19	13
Interest paid	-31.8%	2.18	2.73	7.04
Other inflows (outflows) of cash	-	0	0	0.45
Net Cashflows from Financing Activities	-53.6%	-34.58	-22.17	-19.55
Net change in cash and cash eq.	-115.6%	-8.36	61	30

Consolidated figures (in Rs. Crores) / View Standalone Data

Description	(%) Q/Q	Mar-2024	Mar-2023	Mar-2022
Finance costs	-50.5%	6.44	12	17
Change in inventories	118.4%	16	-80.46	-112.42
Depreciation	-2.2%	45	46	42
Adjustments for interest income	626.6%	22	3.89	0
Net Cashflows from Operations	-46.3%	282	524	315
Income taxes paid (refund)	-56%	63	142	83
Net Cashflows From Operating Activities	-42.5%	220	382	232
Proceeds from sales of PPE	-14.1%	0.03	0.15	0.27
Purchase of property, plant and equipment	111.8%	253	120	148
Purchase of intangible assets	-	1.92	0	0
Interest received	660.9%	22	3.76	0
Other inflows (outflows) of cash	-	73	0	14
Net Cashflows From Investing Activities	14.1%	-159.82	-186.31	-134.22
Repayments of borrowings	-11.9%	38	43	31
Payments of lease liabilities	-	0.08	0	0
Dividends paid	72.2%	32	19	13
Interest paid	-50.5%	6.44	12	17
Other inflows (outflows) of cash	110.9%	1.83	-6.64	-4.93
Net Cashflows from Financing Activities	7.6%	-74.97	-81.23	-66.27
Net change in cash and cash eq.	-114.2%	-15.16	115	32

Description	Share	Value
Amines and Speciality Chemicals	97.0%	310.4 Cr
Hotel Division	3.0%	9.7 Cr
Total		320 Cr

Valuation
Market Cap	4.17 kCr
Price/Earnings (Trailing)	21.86
Price/Sales (Trailing)	2.79
EV/EBITDA	13.71
Price/Free Cashflow	-196.1
MarketCap/EBT	16.53

Fundamentals
Revenue (TTM)	1.49 kCr
Rev. Growth (Yr)	-18.18%
Rev. Growth (Qtr)	-9.96%
Earnings (TTM)	190.63 Cr
Earnings Growth (Yr)	-44.17%
Earnings Growth (Qtr)	-24.88%

Profitability
Operating Margin	16.9%
EBT Margin	16.9%
Return on Equity	9.8%
Return on Assets	8.85%
Free Cashflow Yield	-0.51%

Is Balaji Amines Better than it's peers?

Detailed comparison of Balaji Amines against industry peers, highlighting key financial metrics, valuation ratios, and performance indicators to provide competitive context within the sector.

Ticker	Name	Mkt Cap	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
VINATIORGA	Vinati OrganicsSpecialty Chemicals	17.42 kCr	2.2 kCr	+6.29%	+2.40%	45.09	7.93	+16.41%	+7.41%
AARTIIND	Aarti IndustriesSpecialty Chemicals	15.72 kCr	7.11 kCr	+10.98%	-42.02%	42.84	2.21	+13.53%	-15.30%
ALKYLAMINE	Alkyl Amines ChemicalsSpecialty Chemicals	9.15 kCr	1.57 kCr	+10.62%	-13.83%	51.27	5.85	+3.61%	+12.23%
SUDARSCHEM	Sudarshan Chemical Indus.Dyes And Pigments	8.41 kCr	2.78 kCr	+8.10%	+48.07%	71.35	3.03	+11.89%	-64.49%
GALAXYSURF	Galaxy SurfactantsSpecialty Chemicals	7.55 kCr	4.05 kCr	+3.97%	-18.18%	24.63	1.86	+4.96%	-2.53%

BALAMINES - Balaji Amines Ltd. Share Price

What does Balaji Amines Ltd. do?

Sector Comparison: BALAMINES vs Chemicals & Petrochemicals

Comparative Metrics

Performance Comparison

Share Holdings

Holding Pattern

Share Holding Details

Overall Distribution

Ownership Distribution

Summary of Latest Earnings Report from Balaji Amines

Income Statement for Balaji Amines

Balance Sheet for Balaji Amines

Investor Care

Financial Health

Cash Flow for Balaji Amines

Revenue Breakdown

Valuation

Fundamentals

Profitability

Is Balaji Amines Better than it's peers?

Price to Sales Ratio

Revenue (Last 12 mths)

Net Income (Last 12 mths)